All Hormone Therapy Articles

Adequate testosterone serum levels are required in males and females not just for libido and sexual function but also for cellular growth, healing, maintenance of muscle mass and bone, and central nervous system maintenance of opioid receptors, blood- brain barrier, and dopamine-norepinephrine activity.
When severe pain and stimulation of the pituitary-adrenal-gonadal axis goes unabated over time, exhaustion of some adrenal compounds may develop and, left untreated, may pose a combination of problems.
Since testosterone assists opioids in crossing the blood brain barrier and helps activate a number of central receptors and neurochemicals systems, it is a judicious, ethical, and clinically necessary practice to replace testosterone in female chronic opioid patients—subject to informed consent.
HCG has great potential as an adjunct in the treatment of severe, chronic pain patients—particularly in those who demonstrate hormonal deficiencies or who show progressive wasting and deterioration.
The effect of severe, persistent pain on the hormone system is profoundly negative. If the patient’s hormone system is not kept homeostatic and balanced, the patient with pain will rapidly age and deteriorate. Consequently, the achievement of hormonal balance—not too high or too low—has to be a primary goal of treatment.
Letter to the Editor from Practical Pain Management about using human chorionic gonadotropin (HCG) in the treatment of chronic pain.
In 2011, the FDA took action against seven companies marketing over-the-counter human chorionic gonadotropin (HCG) products that were labeled “homeopathic” for weight loss. This is good for pain practitioners wanting to use HCG for pain treatment. Dr. Tennant explain why.
A letter from a reader of Practical Pain Management on the use of human chorionic gonadotropic (HCG) in the care of chronic pain patients. A pain expert responds.